Fonte: Journal of Fungi. Unidade: ICB
Assuntos: MICROBIOLOGIA, ANTIRRETROVIRAIS, INFECÇÕES POR HIV, CANDIDA ALBICANS, ENZIMAS HIDROLÍTICAS, BIOFILMES, CAMUNDONGOS
ABNT
SANTOS, André L. S. et al. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches. Journal of Fungi, v. 7, n. 6, p. 1-33, 2021Tradução . . Disponível em: https://doi.org/10.3390/jof7060424. Acesso em: 22 ago. 2024.APA
Santos, A. L. S., Silva, L. A. B., Gonçalves, D. de S., Ramos, L. de S., Oliveira, S. S. C., Souza, L. O. P., et al. (2021). Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches. Journal of Fungi, 7( 6), 1-33. doi:10.3390/jof7060424NLM
Santos ALS, Silva LAB, Gonçalves D de S, Ramos L de S, Oliveira SSC, Souza LOP, Oliveira VS, Lins RD, Pinto MR, Muñoz JE, Taborda CP, Branquinha MH. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches [Internet]. Journal of Fungi. 2021 ; 7( 6): 1-33.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3390/jof7060424Vancouver
Santos ALS, Silva LAB, Gonçalves D de S, Ramos L de S, Oliveira SSC, Souza LOP, Oliveira VS, Lins RD, Pinto MR, Muñoz JE, Taborda CP, Branquinha MH. Repositioning Lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans—in silico, in vitro and in vivo approaches [Internet]. Journal of Fungi. 2021 ; 7( 6): 1-33.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3390/jof7060424